Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

Dysfunction of <i>ERG251</i> activates a Zinc transporter contributing to decreased azole susceptibility. by Xin Zhou (54275)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”

Apigenin decrease eosinophil infiltration in colonic tissues from HFD-mice. by Daniela Gentile (5089280)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”

Erythrocyte membrane beta-actin band decrease intensities in RTT patients. by Alessio Cortelazzo (543292)

Expression of HCMV US proteins by MSC decreases PBMNC proliferation and correlates with the levels of HLA-I. by Melisa A. Soland (162129)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

Normalized pressure pain thresholds (PPTs) (mean ± SEM) at start, middle, end and 5 minutes after a standardized tourniquet test. by Jeanette Tour (10790855)

Induction of a VSG synthesis block leads to a decrease in clearance of surface-bound anti-VSG221 antibodies. by Jackie L. Y. Cheung (3365033)

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

Decrease in the number of intestinal pDCs in <i>Enpp3</i>^<i>-/-</i> mice. by Yoki Furuta (3772735)

Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

“…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”

Increase in intracellular cAMP inhibits decreased RSV A2 F mRNA in epithelial monolayers. by Fariba Rezaee (366381)

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…<p>(A) Microarray gene expression analysis of postmortem dorsolateral PFC (DLPFC) samples collected from patients with PTSD shows decreased levels of SGK1 mRNA. …”